Literature DB >> 33164718

Systemic mastocytosis with subcutaneous hemorrhage and edema in a Greyhound dog: case report and review of diagnostic criteria.

Alexander Aceino1, Unity Jeffery1, Julie Piccione2, Carolyn L Hodo1,3.   

Abstract

Systemic mastocytosis, characterized by infiltration of multiple organs by neoplastic mast cells, is a well-described entity in human medicine with specific criteria for diagnosis, but is ill defined in veterinary literature. Hemostatic disorders are reported in humans affected by systemic mastocytosis but have not been well described in veterinary literature. A 5-y-old, spayed female Greyhound dog had a 1-mo history of progressive ventral cutaneous edema, hemorrhage, and pain. Cytology of an antemortem aspirate from the subcutis of the ventral abdomen was suggestive of mast cell neoplasia, but no discrete mass was present. The dog was euthanized and submitted for autopsy; marked subcutaneous edema and hemorrhage were confirmed. The ventral abdominal panniculus and dermis superficial to the panniculus carnosus were infiltrated by a dense sheet of neoplastic mast cells. The neoplastic cells contained toluidine blue-positive granules and formed aggregates within the bone marrow and several visceral organs, including the liver, spleen, heart, and kidney. Diffuse edema and hemorrhage is an unusual presentation of mast cell tumors in dogs. Antemortem tests, including complete blood count, coagulation profile, and viscoelastic coagulation testing, were suggestive of a primary hemostatic defect. We discuss here the diagnostic criteria used in humans, how these can be applied to veterinary patients, and the limitations of the current diagnostic framework.

Entities:  

Keywords:  canine; coagulation; edema; hemorrhage; mastocytosis; neoplasia; pathology

Mesh:

Year:  2020        PMID: 33164718      PMCID: PMC7758694          DOI: 10.1177/1040638720972500

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  19 in total

1.  Effects of skin mast cells on bleeding time and coagulation activation at the site of platelet plug formation.

Authors:  P Kauhanen; P T Kovanen; T Reunala; R Lassila
Journal:  Thromb Haemost       Date:  1998-04       Impact factor: 5.249

2.  Cutaneous and systemic porcine mastocytosis.

Authors:  A Bundza; T W Dukes
Journal:  Vet Pathol       Date:  1982-07       Impact factor: 2.221

Review 3.  Mastocytosis: pathology, genetics, and current options for therapy.

Authors:  Peter Valent; Cem Akin; Wolfgang R Sperr; Matthias Mayerhofer; Manuela Födinger; Robert Fritsche-Polanz; Karl Sotlar; Luis Escribano; Michel Arock; Hans-Peter Horny; Dean D Metcalfe
Journal:  Leuk Lymphoma       Date:  2005-01

Review 4.  Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment.

Authors:  Monika M Welle; Carla Rohrer Bley; Judith Howard; Silvia Rüfenacht
Journal:  Vet Dermatol       Date:  2008-12       Impact factor: 1.589

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

6.  The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.

Authors:  M Kiupel; J D Webster; J B Kaneene; R Miller; V Yuzbasiyan-Gurkan
Journal:  Vet Pathol       Date:  2004-07       Impact factor: 2.221

7.  Systemic mastocytosis in 16 dogs.

Authors:  D A O'Keefe; C G Couto; C Burke-Schwartz; R M Jacobs
Journal:  J Vet Intern Med       Date:  1987 Apr-Jun       Impact factor: 3.333

8.  Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells.

Authors:  Karoline V Gleixner; Laura Rebuzzi; Matthias Mayerhofer; Alexander Gruze; Emir Hadzijusufovic; Karoline Sonneck; Anja Vales; Michael Kneidinger; Puchit Samorapoompichit; Tuddow Thaiwong; Winfried F Pickl; Vilma Yuzbasiyan-Gurkan; Christian Sillaber; Michael Willmann; Peter Valent
Journal:  Exp Hematol       Date:  2007-08-02       Impact factor: 3.084

9.  Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors.

Authors:  Sébastien Letard; Ying Yang; Katia Hanssens; Fabienne Palmérini; Phillip S Leventhal; Stéphanie Guéry; Alain Moussy; Jean-Pierre Kinet; Olivier Hermine; Patrice Dubreuil
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

10.  Cutaneous mastocytosis with bleeding: probable heparin effect.

Authors:  T F Smith; T R Welch; J B Allen; J M Sondheimer
Journal:  Cutis       Date:  1987-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.